Tuesday, June 18, 2013
Submit a News Story
Aprea Announces Positive Data from a Clinical Phase I/II Study with APR-246
Published: Wednesday, September 19, 2012
Last Updated: Wednesday, September 19, 2012
Results from the study have been published in the Journal of Clinical Oncology.
Full access to this article is for registered users only.
is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.
Developmental Protein Plays Role in Spread of Cancer
A protein used by embryo cells during early development, and recently found in many different types of cancer, apparently serves as a switch regulating metastasis.
Two Gene Variants May Predict Who Will Benefit from Breast Cancer Prevention Drugs
NIH-supported discovery could advance individualized care of high-risk women.
Supreme Court Rules That Human Genes Can’t Be Patented
Most agree that the ruling reduces barriers to genetic testing and enables scientists to further genetic research and share data aimed ultimately at preventing and curing disease.
Researchers Find Unique Peptide with Therapeutic Potential
UTSW researchers identify Tat-beclin 1 against cancers, neurological disorders, and infectious diseases.
Genetic Switches Play Big Role in Human Evolution
Study offers further proof that the divergence of humans from chimpanzees was profoundly influenced by mutations to DNA sequences.
An Epigenetic Change Causes the Block of Antitumor Genes
Healthy cells live in a delicate balance between growth-promoting genes (oncogenes) and those who restrain it (anti-oncogenes or tumor suppressor genes).
Vegetable Fats Tied to Less Prostate Cancer Spread
After being diagnosed with prostate cancer, men who eat a diet high in vegetable fats may be less likely to have their disease spread.
Studies Illuminate Functions of RNA
Researchers at the University of California illuminate the functional importance of a relatively new class of RNA molecules.
Therapeutic Nanoparticles from Grapefruit Juice
Grapefruit-derived nanovectors to deliver targeted drugs to treat cancer.
Chemical Screen Points to New Line of Attack Against Neuroblastoma
In the war on neuroblastoma, the current chemical weaponry is reaching its limit.
Advertise On This Site
Terms & Conditions
©2013 Technology Networks
, all rights reserved.